Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Bolla

Showing results (101-110 of 158) with videos related to

Pageof 16
Sort By:
European Urology|February 15, 2011
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancerNicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al.
European Urology|November 12, 2013
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013Axel Heidenreich, Patrick J Bastian, Joaquim Bellmunt, et al.
Communications Biology|August 25, 2022
The membrane-active polyaminoisoprenyl compound NV716 re-sensitizes Pseudomonas aeruginosa to antibiotics and reduces bacterial virulenceGang Wang, Jean-Michel Brunel, Matthias Preusse, et al.
Scientific Reports|February 20, 2021
Tolerance engineering in Deinococcus geothermalis by heterologous efflux pumpsErika Boulant, Emmanuelle Cambon, Julia Vergalli, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2005
Patients at high risk of progression after radical prostatectomy: do they all benefit from immediate post-operative irradiation? (EORTC trial 22911)Laurence Collette, Hein van Poppel, Michel Bolla, et al.
Plos One|August 18, 2009
pH Modulation of efflux pump activity of multi-drug resistant Escherichia coli: protection during its passage and eventual colonization of the colonAna Martins, Gabriella Spengler, Liliana Rodrigues, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 18, 2010
Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: preliminary results of a multicentre phase II trialMichel Bolla, Jean Michel Hannoun-Levi, Jean-Marc Ferrero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Prognostic factors for survival in adult patients with cerebral low-grade gliomaFrancesco Pignatti, Martin van den Bent, Desmond Curran, et al.
Scientific Reports|October 21, 2016
A unique peptide deformylase platform to rationally design and challenge novel active compoundsSonia Fieulaine, Rodolphe Alves de Sousa, Laure Maigre, et al.
Virchows Archiv : an International Journal of Pathology|August 31, 2006
Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911)Theodorus H van der Kwast, Laurence Collette, Hein Van Poppel, et al.
Pageof 16

Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
European Urology|February 15, 2011
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancerNicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al.
European Urology|November 12, 2013
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013Axel Heidenreich, Patrick J Bastian, Joaquim Bellmunt, et al.
Communications Biology|August 25, 2022
The membrane-active polyaminoisoprenyl compound NV716 re-sensitizes Pseudomonas aeruginosa to antibiotics and reduces bacterial virulenceGang Wang, Jean-Michel Brunel, Matthias Preusse, et al.
Scientific Reports|February 20, 2021
Tolerance engineering in Deinococcus geothermalis by heterologous efflux pumpsErika Boulant, Emmanuelle Cambon, Julia Vergalli, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2005
Patients at high risk of progression after radical prostatectomy: do they all benefit from immediate post-operative irradiation? (EORTC trial 22911)Laurence Collette, Hein van Poppel, Michel Bolla, et al.
Plos One|August 18, 2009
pH Modulation of efflux pump activity of multi-drug resistant Escherichia coli: protection during its passage and eventual colonization of the colonAna Martins, Gabriella Spengler, Liliana Rodrigues, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 18, 2010
Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: preliminary results of a multicentre phase II trialMichel Bolla, Jean Michel Hannoun-Levi, Jean-Marc Ferrero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Prognostic factors for survival in adult patients with cerebral low-grade gliomaFrancesco Pignatti, Martin van den Bent, Desmond Curran, et al.
Scientific Reports|October 21, 2016
A unique peptide deformylase platform to rationally design and challenge novel active compoundsSonia Fieulaine, Rodolphe Alves de Sousa, Laure Maigre, et al.
Virchows Archiv : an International Journal of Pathology|August 31, 2006
Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911)Theodorus H van der Kwast, Laurence Collette, Hein Van Poppel, et al.
Pageof 16